NCT07815197
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07815197
Title Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancer (PERSEUS)
Acronym PERSEUS
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Latin American Cooperative Oncology Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries BRA

Facility Status City State Zip Country Details
Instituto D'Or de Pesquisa e Ensino Ceará Fortaleza Ceará 60135-237 Brazil Details
ICC - Instituto do Câncer do Ceará Fortaleza Ceará 60430-230 Brazil Details
Santa Casa de Misericórdia da Bahia - Hospital Santa Izabel (Oncoclínicas) Salvador Estado de Bahia 40050-410 Brazil Details
Hospital Sírio-Libanês DF Brasília Federal District 70200-730 Brazil Details
IEPAM - Instituto de Ensino e Pesquisa da Amazônia Belém Pará 66093-020 Brazil Details
ISEP - Instituto Santa Joana de Ensino e Pesquisa (Rede Américas) Recife Pernambuco 52011-000 Brazil Details
Liga Norte Riograndense Contra o Câncer Natal Rio Grande do Norte 59062-000 Brazil Details
ISCMPA - Santa Casa de Porto Alegre Porto Alegre Rio Grande do Sul 90050-170 Brazil Details
Futtura Oncologia - Hub de Pesquisa Clínica Porto Alegre Rio Grande do Sul Rio Grande do Sul Brazil Details
Hospital de Amor de Barretos Barretos São Paulo 14784-400 Brazil Details
BP - A Beneficência Portuguesa de São Paulo São Paulo São Paulo 01323-030 Brazil Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field